The vascular disrupting agent ZD6126 shows increased antitumor efficacy and enhanced radiation response in large, advanced tumors
- 1 July 2005
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 62 (3) , 846-853
- https://doi.org/10.1016/j.ijrobp.2005.02.048
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Vascular‐targeting therapies for treatment of malignant diseaseCancer, 2004
- Vascular Targeting Agents as Cancer TherapeuticsClinical Cancer Research, 2004
- Overview of angiogenesis: Biologic implications for antiangiogenic therapySeminars in Oncology, 2001
- Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcomeRadiotherapy and Oncology, 1999
- New strategies in anti‐vascular cancer therapyEuropean Journal of Clinical Investigation, 1999
- Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neckRadiotherapy and Oncology, 1996
- Intratumoral pO2 predicts survival in advanced cancer of the uterine cervixRadiotherapy and Oncology, 1993
- Angiogenesis.Journal of Biological Chemistry, 1992
- Blood Flow, Oxygen Consumption and Tissue Oxygenation of Human TumorsPublished by Springer Nature ,1990
- Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesisMicrovascular Research, 1977